Skip to main content

Table 8 Change in asthma control and asthma quality of life scores at 6-months for increased ICS and decreased ICS dose groups

From: A self-rating scale for patient-perceived side effects of inhaled corticosteroids

Scale

Increased ICS Dose (n = 21)

Decreased ICS Dose (n = 18)

 

BL

6M

BL

6M

ACQ Total Score

1.5 (0.8, 2.3)

1.2 (0.7, 1.8)**

0.7 (0.3, 1.3)

0.8 (0.2, 1.4)

AQLQ(S) Total Score

5.1 (4.5, 5.9)

5.7 (5.1, 6.3)*†

6.0 (5.3, 6.6)

6.3 (5.5, 6.8)

  1. All data median (IQR); ACQ (0–6) scored: 0 = best control, 6 = worst control; AQLQ(S) (7–1) scored: 7 = best, 1 = worst
  2. Change from baseline tested with Wilcoxon *p = 0.001 ** p = 0.039
  3. †Clinically important change (≥0.5 on scale)